{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T04:35:39Z","timestamp":1788150939536,"version":"build-2803163510"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Cirrhotic cardiomyopathy is a cardiac abnormality due to hepatic cirrhosis, which presents as a serious electrocardiographic complication and often the patient is asymptomatic. The objective of our study was to find the ECG changes in patients with various aetiologies of cirrhosis and correlate them with their respective LFT parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methodology:<\/jats:title>\n                    <jats:p>We assessed the QTc interval in patients of various aetiologies of liver cirrhosis and correlated them with the prevalence of complication of cirrhosis, such as portal hypertension, splenomegaly, and ascites. Furthermore, we correlated the LFT parameters with their respective QTc interval.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Our study evaluated 300 patients of multiple aetiologies of cirrhosis, such as ALD, NASH, DCLD, AIH, HCC, HA, Hep-B, and Wilson\u2019s disease. Prolonged QTc was observed in 194 (64.66%) patients. QTc prolongation was most prevalent in DCLD patients. The association of complication including portal hypertension, splenomegaly, and ascites with prolonged QTc were all statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = &lt;0.001). QTc ms was significantly related to the Child\u2013Pugh class (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = &lt;0.001). SGOT and SGPT parameters were significantly correlated with QTc intervals (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = &lt;0.001) in all aetiologies of liver disease. However, the correlation between ALP and indirect bilirubin levels with QTc interval was not statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Prolonged QTc interval is frequently observed as the ECG abnormality in patients with cirrhosis. QT prolongation correlates with elevated LFTs and cirrhotic complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_1814_24","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T10:00:10Z","timestamp":1751277610000},"page":"2323-2329","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Association of QTc prolongation with liver function test and complications in patients with cirrhosis: An observational study"],"prefix":"10.4103","volume":"14","author":[{"given":"Rhythm Yogandh","family":"Relekar","sequence":"first","affiliation":[{"name":"DY Patil Deemed to be University School of Medicine, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyavardhan","family":"Mishra","sequence":"additional","affiliation":[{"name":"DY Patil Deemed to be University School of Medicine, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal Raghunath","family":"Gabale","sequence":"additional","affiliation":[{"name":"Department of General Medicine, DY Patil Deemed to be University School of Medicine, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqra Chandmiya","family":"Qureshi","sequence":"additional","affiliation":[{"name":"DY Patil Deemed to be University School of Medicine, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaykumar","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Physiology, Chirayu Medical College and Hospital, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"R2-20250707","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cld.2021.01.012","article-title":"Current concepts of cirrhotic cardiomyopathy","volume":"25","author":"Izzy","year":"2021","journal-title":"Clin Liver Dis"},{"key":"R3-20250707","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12072-014-9531-y","article-title":"Cirrhotic cardiomyopathy: Review of pathophysiology and treatment","volume":"8","author":"Chayanupatkul","year":"2014","journal-title":"Hepatol Int"},{"key":"R4-20250707","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1172-2-15","article-title":"Cirrhotic cardiomyopathy","volume":"2","author":"Baik","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"R5-20250707","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/medicina56020068","article-title":"Electrocardiographic changes in liver cirrhosis-clues for cirrhotic cardiomyopathy","volume":"56","author":"Toma","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"R6-20250707","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ncpgasthep0498","article-title":"Therapy insight: Cirrhotic cardiomyopathy","volume":"3","author":"Gaskari","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"R7-20250707","doi-asserted-by":"crossref","first-page":"e7809","DOI":"10.1590\/1414-431x20187809","article-title":"Cirrhotic cardiomyopathy: The liver affects the heart","volume":"52","author":"Carvalho","year":"2019","journal-title":"Braz J Med Biol Res"},{"key":"R8-20250707","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/clc.24089","article-title":"Electrocardiographic characteristics of cirrhotic patients and their association with Child-Pugh score","volume":"46","author":"Jahangiri","year":"2023","journal-title":"Clin Cardiol"},{"key":"R9-20250707","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrgastro.2013.210","article-title":"Cirrhotic cardiomyopathy: Pathogenesis and clinical relevance","volume":"11","author":"Wiese","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R10-20250707","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1586\/egh.11.86","article-title":"QT interval prolongation in liver cirrhosis: Innocent bystander or serious threat?","volume":"6","author":"Bernardi","year":"2012","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R11-20250707","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.rmed.2013.03.010","article-title":"Cirrhotic cardiomyopathy and hepatopulmonary syndrome: Prevalence and prognosis in a series of patients","volume":"107","author":"Enache","year":"2013","journal-title":"Respir Med"},{"key":"R12-20250707","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1161\/CIRCULATIONAHA.119.039598","article-title":"The QT interval","volume":"139","author":"Giudicessi","year":"2019","journal-title":"Circulation"},{"key":"R13-20250707","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1042\/CS20080325","article-title":"QT interval prolongation and decreased heart rate variability in cirrhotic patients: Relevance of hepatic venous pressure gradient and serum calcium","volume":"116","author":"Genovesi","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"R14-20250707","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.4103\/jfmpc.jfmpc_341_20","article-title":"QTc prolongation in patients of cirrhosis and its relation with disease severity: An observational study from a rural teaching hospital","volume":"9","author":"Bhardwaj","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"R15-20250707","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/0140-6736(93)90879-L","article-title":"QT prolongation and sudden cardiac death in patients with alcoholic liver disease","volume":"341","author":"Day","year":"1993","journal-title":"Lancet"},{"key":"R16-20250707","first-page":"68","article-title":"Alcohol, cardiac arrhythmias and sudden death","volume":"216","author":"Kupari","year":"1998","journal-title":"Novartis Found Symp"},{"key":"R17-20250707","doi-asserted-by":"crossref","first-page":"662","DOI":"10.4254\/wjh.v7.i4.662","article-title":"Arrhythmia risk in liver cirrhosis","volume":"7","author":"Mozos","year":"2015","journal-title":"World J Hepatol"},{"key":"R18-20250707","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/hep.510270106","article-title":"Q-T interval prolongation in cirrhosis: Prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors","volume":"27","author":"Bernardi","year":"1998","journal-title":"Hepatology"},{"key":"R19-20250707","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/clc.4960221013","article-title":"Prolongation of the QT interval in children with liver failure","volume":"22","author":"Fishberger","year":"1999","journal-title":"Clin Cardiol"},{"key":"R20-20250707","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1399-3046.2008.00909.x","article-title":"Impact of liver transplantation on rate-corrected QT interval and myocardial function in children with chronic liver disease*","volume":"13","author":"Arikan","year":"2009","journal-title":"Pediatr Transplant"},{"key":"R21-20250707","doi-asserted-by":"crossref","first-page":"e007792","DOI":"10.1161\/JAHA.117.007792","article-title":"Bilirubin is inversely associated with cardiovascular disease among HIV-positive and HIV-negative individuals in VACS (Veterans Aging Cohort Study)","volume":"7","author":"Marconi","year":"2018","journal-title":"J Am Heart Assoc"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1814_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:35:05Z","timestamp":1787067305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1814_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1814_24","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"2024-11-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}